Skip to main content
TipRanks
Go Ultimate75% OFF
Beyang Therapeutics Co Ltd logo

Beyang Therapeutics Co Ltd: Valuation, Funding & Investors

An AI-driven innovative drug R&D company focused on accelerating drug discovery through proprietary computational platforms. The company develops differentiated therapeutic pipelines, including a second-generation Menin inhibitor and a novel ophthalmic therapy, and advances candidates toward global clinical development.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$30M
Total Funding Rounds
1
Latest Funding Amount
$30M
Latest Funding Round
Series A

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Aug 12, 2026Series A$30.00M―

Similar Companies

A snapshot of private companies similar to Beyang Therapeutics Co Ltd, helping you discover and navigate related company profiles.

Related News and Analysis